Aprea Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of APRE for the last quarter is 354.62 k USD, and it's 36.85% lower compared to the previous quarter. The net income of Q3 24 is -3.78 M USD.